XOMA
Price
$31.10
Change
+$0.10 (+0.32%)
Updated
Dec 4, 04:59 PM (EDT)
Capitalization
383.88M
91 days until earnings call
Intraday BUY SELL Signals
ZNTL
Price
$1.40
Change
+$0.02 (+1.45%)
Updated
Dec 4, 04:59 PM (EDT)
Capitalization
99.71M
90 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

XOMA vs ZNTL

Header iconXOMA vs ZNTL Comparison
Open Charts XOMA vs ZNTLBanner chart's image
XOMA Royalty
Price$31.10
Change+$0.10 (+0.32%)
Volume$900
Capitalization383.88M
Zentalis Pharmaceuticals
Price$1.40
Change+$0.02 (+1.45%)
Volume$16.07K
Capitalization99.71M
XOMA vs ZNTL Comparison Chart in %
XOMA
Daily Signal:
Gain/Loss:
ZNTL
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
XOMA vs. ZNTL commentary
Dec 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is XOMA is a Hold and ZNTL is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 05, 2025
Stock price -- (XOMA: $31.00 vs. ZNTL: $1.38)
Brand notoriety: XOMA and ZNTL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: XOMA: 182% vs. ZNTL: 71%
Market capitalization -- XOMA: $383.88M vs. ZNTL: $99.71M
XOMA [@Biotechnology] is valued at $383.88M. ZNTL’s [@Biotechnology] market capitalization is $99.71M. The market cap for tickers in the [@Biotechnology] industry ranges from $117.5B to $0. The average market capitalization across the [@Biotechnology] industry is $2.2B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

XOMA’s FA Score shows that 1 FA rating(s) are green whileZNTL’s FA Score has 1 green FA rating(s).

  • XOMA’s FA Score: 1 green, 4 red.
  • ZNTL’s FA Score: 1 green, 4 red.
According to our system of comparison, XOMA is a better buy in the long-term than ZNTL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

XOMA’s TA Score shows that 4 TA indicator(s) are bullish while ZNTL’s TA Score has 4 bullish TA indicator(s).

  • XOMA’s TA Score: 4 bullish, 4 bearish.
  • ZNTL’s TA Score: 4 bullish, 7 bearish.
According to our system of comparison, XOMA is a better buy in the short-term than ZNTL.

Price Growth

XOMA (@Biotechnology) experienced а -4.00% price change this week, while ZNTL (@Biotechnology) price change was -4.17% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.21%. For the same industry, the average monthly price growth was +5.86%, and the average quarterly price growth was +56.03%.

Reported Earning Dates

XOMA is expected to report earnings on Mar 05, 2026.

ZNTL is expected to report earnings on Mar 04, 2026.

Industries' Descriptions

@Biotechnology (+1.21% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
XOMA($384M) has a higher market cap than ZNTL($99.7M). XOMA YTD gains are higher at: 17.960 vs. ZNTL (-54.455). XOMA has higher annual earnings (EBITDA): -305K vs. ZNTL (-170.37M). ZNTL has more cash in the bank: 303M vs. XOMA (83.9M). ZNTL has less debt than XOMA: ZNTL (37.7M) vs XOMA (115M). ZNTL has higher revenues than XOMA: ZNTL (26.9M) vs XOMA (12.8M).
XOMAZNTLXOMA / ZNTL
Capitalization384M99.7M385%
EBITDA-305K-170.37M0%
Gain YTD17.960-54.455-33%
P/E Ratio41.33N/A-
Revenue12.8M26.9M48%
Total Cash83.9M303M28%
Total Debt115M37.7M305%
FUNDAMENTALS RATINGS
XOMA: Fundamental Ratings
XOMA
OUTLOOK RATING
1..100
74
VALUATION
overvalued / fair valued / undervalued
1..100
2
Undervalued
PROFIT vs RISK RATING
1..100
85
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
59
P/E GROWTH RATING
1..100
48
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
XOMAZNTL
RSI
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
79%
MACD
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
79%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 9 days ago
77%
Bullish Trend 10 days ago
82%
Declines
ODDS (%)
Bearish Trend 14 days ago
78%
Bearish Trend 15 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
XOMA
Daily Signal:
Gain/Loss:
ZNTL
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IFUS0.04N/A
+7.53%
Impact Fusion International Inc.
ANOIX23.630.32
+1.37%
American Century Small Cap Growth Inv
DRTCX21.840.03
+0.14%
BNY Mellon Sust US Equity I
EKJAX12.66N/A
N/A
Allspring Premier Large Co Gr A
PMHG54.31N/A
N/A
Prime Meridian Holding Co.

XOMA and

Correlation & Price change

A.I.dvisor indicates that over the last year, XOMA has been loosely correlated with SYRE. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if XOMA jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XOMA
1D Price
Change %
XOMA100%
+4.17%
SYRE - XOMA
42%
Loosely correlated
+13.38%
FHTX - XOMA
41%
Loosely correlated
+3.50%
BDTX - XOMA
40%
Loosely correlated
-22.03%
FENC - XOMA
38%
Loosely correlated
-0.53%
ZNTL - XOMA
38%
Loosely correlated
+2.99%
More

ZNTL and

Correlation & Price change

A.I.dvisor indicates that over the last year, ZNTL has been loosely correlated with NGNE. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ZNTL jumps, then NGNE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZNTL
1D Price
Change %
ZNTL100%
+2.99%
NGNE - ZNTL
48%
Loosely correlated
+4.57%
MGNX - ZNTL
48%
Loosely correlated
-1.41%
SYRE - ZNTL
47%
Loosely correlated
+13.38%
RXRX - ZNTL
45%
Loosely correlated
+7.87%
FATE - ZNTL
45%
Loosely correlated
+7.46%
More